Kathiresan Sekar, Larson Martin G, Keyes Michelle J, Polak Joseph F, Wolf Philip A, D'Agostino Ralph B, Jaffer Farouc A, Clouse Melvin E, Levy Daniel, Manning Warren J, O'Donnell Christopher J
Framingham Heart Study, Framingham, Massachusetts, USA.
Am J Cardiol. 2007 Feb 1;99(3):310-4. doi: 10.1016/j.amjcard.2006.08.028. Epub 2006 Dec 14.
Screening for subclinical atherosclerosis has been advocated for individuals at intermediate global risk for coronary heart disease (CHD). However, the distribution of subclinical atherosclerosis test values across CHD risk strata is unknown. We studied a stratified random sample of 292 participants (mean age 59.5 years, 50% women) from the offspring cohort of the Framingham Heart Study who were free of clinically apparent cardiovascular disease. We assessed abdominal and thoracic aortic plaque burden by cardiovascular magnetic resonance (CMR), coronary artery calcification (CAC) and thoracic aortic calcification (TAC) by electron beam computed tomography, and common carotid intima-media thickness (C-IMT) by ultrasonography. We categorized the upper 20% of each measurement as a high level of atherosclerosis and evaluated these variables across clinically relevant Framingham CHD risk score strata (low, intermediate, and high risk). In age-adjusted analyses in men and women, correlations across CMR aortic plaque, CAC, TAC, and C-IMT were low (maximum r = 0.30 for CAC:TAC in women, p <0.005). In men and women, the proportion of subjects with high atherosclerosis test results for any of these measurements increased significantly across Framingham CHD risk score strata (Kruskal-Wallis test, p <0.0001). In the intermediate Framingham CHD risk score category, 14% of men and 25% of women had a high atherosclerosis result on >or=2 measurements. However, different participants were identified as having high atherosclerosis by each modality. For example, in a comparison of the overlap across CMR aortic plaque, CAC, and C-IMT, only 4% of men and 16% of women were classified as having high atherosclerosis on all 3 measurements. In conclusion, in a community-based sample, correlations among subclinical atherosclerosis test results are low, and a substantial proportion has high levels of subclinical atherosclerosis detected on >or=2 imaging tests.
对于冠心病(CHD)中具有中等总体风险的个体,已提倡进行亚临床动脉粥样硬化筛查。然而,亚临床动脉粥样硬化检测值在冠心病风险分层中的分布尚不清楚。我们研究了来自弗雷明汉心脏研究后代队列的292名参与者(平均年龄59.5岁,50%为女性)的分层随机样本,这些参与者无临床明显心血管疾病。我们通过心血管磁共振成像(CMR)评估腹主动脉和胸主动脉斑块负荷,通过电子束计算机断层扫描评估冠状动脉钙化(CAC)和胸主动脉钙化(TAC),并通过超声检查评估颈总动脉内膜中层厚度(C-IMT)。我们将每项测量值的前20%归类为高水平动脉粥样硬化,并在临床相关的弗雷明汉冠心病风险评分分层(低、中、高风险)中评估这些变量。在对男性和女性进行年龄调整分析时,CMR主动脉斑块、CAC、TAC和C-IMT之间的相关性较低(女性中CAC与TAC的最大r值为0.30,p<0.005)。在男性和女性中,这些测量中任何一项具有高动脉粥样硬化检测结果的受试者比例在弗雷明汉冠心病风险评分分层中显著增加(Kruskal-Wallis检验,p<0.0001)。在弗雷明汉冠心病风险评分中等类别中,14%的男性和25%的女性在≥2项测量中有高动脉粥样硬化结果。然而,每种检测方法识别出的具有高动脉粥样硬化的参与者不同。例如,在比较CMR主动脉斑块、CAC和C-IMT之间的重叠情况时,只有4%的男性和16%的女性在所有3项测量中被归类为具有高动脉粥样硬化。总之,在基于社区的样本中,亚临床动脉粥样硬化检测结果之间的相关性较低,并且相当一部分人在≥2项影像学检查中检测到高水平的亚临床动脉粥样硬化。